Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
Polyethylene glycol 6000 (PEG 6000) traces its journey back to the early 20th century, in a period marked by rapid advances in polymer chemistry. Dr. John W. Hill and his contemporaries first experimented with ethylene oxide's polymerization, unknowingly setting the stage for a versatile chemical. Interest in PEGs picked up due to their unique solubility, low toxicity, and predictable molecular weights. Pharmacists and chemists quickly realized that PEG 6000, with its higher molecular weight, brought something fresh to the table. Over the years, compendia like the British Pharmacopoeia (BP), European Pharmacopoeia (EP), and United States Pharmacopeia (USP) began to recognize and specify PEG 6000, standardizing its use across continents. These standardized grades shaped everything from ointments in a 1940s apothecary to advanced controlled-release formulations found in today's hospitals.
PEG 6000 lives up to its reputation by dissolving seamlessly in water and many organic solvents. Its molecular weight hovers around 7000 daltons, which grants it a solid, waxy texture at ambient temperatures. The product flows smoothly, looks clean, and lacks any odor—something that's just as appreciated in the lab as on the production line. With repeat units of ethylene oxide strung together into long chains, PEG 6000 absorbs water but resists breaking down under normal storage conditions. These physical traits, along with tight control over contaminants like diethylene glycol, give users the confidence to blend PEG 6000 into formulations ranging from tablets to lozenges.
Lab workers pay close attention to the technical sheet. PEG 6000 comes with a melting range hovering around 60–63°C, viscosity near 130–160 cP (for a 20% solution at 20°C), and a pH that stays between 4.5 and 7.5 (for a 5% solution). Water content runs under 1%, heavy metal impurities must stay below 5 parts per million, and acidity and alkalinity markers remind users that every batch gets scrutinized. Standardized packaging, usually in fiber drums lined with polythene, keeps exposure to air and light in check. Detailed batch numbers and expiry dates follow GDP protocols, giving end-users full traceability from plant to pharmacy.
Making PEG 6000 starts with ethylene oxide and a catalyst like sulfuric acid or sodium hydroxide. These ingredients enter large reaction vessels, where precise temperature and pressure conditions give rise to polymer chains of a desired length. The reaction stops at a certain point, followed by neutralization and removal of by-products through distillation and filtration. The resulting polymer gets dried, flaked, or ground, then subjected to further purification steps. Industrial producers monitor impurity profiles tightly and confirm molecular distribution by methods like gel permeation chromatography. Finished material passes through sieves, then heads for quality testing before reaching the packaging line.
PEG 6000 contains plenty of ether linkages and terminal hydroxyl groups, making it reactive when it comes into contact with strong acids, oxidizers, or certain crosslinking agents. Its main functionality sits in those two hydroxyl groups at each end of the molecule. PEG 6000 can react to form esters, ethers, and urethanes. Pharmaceutical scientists tweak those ends to make prodrugs and improve delivery profiles. Sometimes, they link PEG 6000 to proteins or nanoparticles, slowing clearance from the bloodstream and smoothing out drug absorption. Though stable under neutral or slightly acidic and basic conditions, PEG 6000 shouldn't meet strong acids or bases for extended periods, as degradation might occur.
Anyone who’s worked with multiple suppliers knows PEG 6000 by many names: Carbowax 6000, Polyglycol 6000, Poly(Oxy-1,2-Ethanediyl) 6000, and Glycol Polyethylene. Labels in Europe might read Macrogol 6000, as “macrogol” catches on in EMEA drug monographs. Renowned chemical manufacturers commonly include trade names like Lutrol E4000 or Polyox WSR N-80, although molecular weights can overlap in branding. For researchers, catalog numbers and CAS No. 25322-68-3 offer a more foolproof ID system.
I have relied on PEG 6000 with the peace of mind that it meets strict standards for pharma-grade excipients. Factories granting BP/EP/USP certification submit every lot to orthogonal testing for purity, endotoxin levels, and bioburden. Workers must wear gloves, goggles, and dust masks to avoid eye and skin contact, even if toxicology profiles promise a broad safety margin. Storage in cool, dry conditions away from reactive chemicals extends shelf life. Transporters follow ADR, IMDG, and IATA regulations, given the global rush for drug ingredients. In a well-run lab or warehouse, spill kits and eyewash stations stay close to where PEG is handled, ensuring an added measure of protection.
I’ve watched PEG 6000 take on roles across multiple industries, but nowhere more prominently than in pharmacy and biotechnology. In oral drug forms, PEG 6000 serves as a binder, coating agent, matrix builder, and lubricant. It pops up in creams, gels, and suppositories for its ability to carry active ingredients evenly. Outside pharma, cosmetics manufacturers find PEG 6000 indispensable for stabilizing emulsions, plumping up lotions, and keeping lipsticks from drying out. The food sector leans on its non-toxicity for glazing and preservation. More recently, bioengineering groups explore PEG 6000’s use in hydrogels for tissue scaffolds and drug-delivery microspheres, harnessing the polymer’s biocompatibility and solubility.
Academic and industrial researchers uncover new uses for PEG 6000 almost yearly. Lab teams report using it to mimic crowding conditions inside living cells, allowing studies in protein folding and enzyme kinetics. Diagnostic companies coax PEG 6000 into precipitating DNA or proteins during sample preparation. Nanomedicine researchers craft PEGylated beads and carriers, targeting elusive diseases like cancer or neurodegeneration. Many journals describe integrating PEG 6000 into 3D-printed tissue constructs, pointing toward a future where polymer chemistry and regenerative medicine walk hand in hand. Funding agencies see promise not only in its direct medical uses but also in its environmental contributions, like water treatment and green chemistry.
Toxicological studies back up PEG 6000’s broad use in medicine and industry. After reviewing countless preclinical reports, it stands out that even high doses rarely trigger adverse reactions in animals or humans. Oral LD50 values sit comfortably above the limit for concern, and metabolic breakdown occurs mainly through passive excretion rather than enzymatic change. Allergic responses stay very rare, and PEG’s long record in eye drops, skin products, and injectables offers reassurance. Yet, as with any widely used compound, vigilance in quality control and monitoring for contamination (especially with lower-weight glycols) guards against unnecessary risk. Regulatory agencies, including the EMA and FDA, periodically review safety profiles and update standards as analytical techniques advance.
With advanced biologics, gene therapies, and personalized medicine taking the stage, PEG 6000 keeps finding new uses. I see startups and large drug companies alike exploring how PEGylation extends drug half-life or improves targeting. The rising field of biosimilars adds steady demand, while stricter environmental policies have companies rethinking how they source PEG intermediates. Green chemistry aims to use less toxic catalysts or renewable feedstock, responding to climate change and resource scarcity. Meanwhile, regulators tighten tolerances on trace impurities and residual solvents, nudging manufacturers toward better purification and documentation. As digital tracking improves and AI-driven design enters the excipient market, PEG 6000 will likely continue serving researchers and patients from every corner of the world.
I’ve spent some time working around the world of pharmaceuticals, and you get used to odd-shaped powders and tongue-twisting names. Polyethylene Glycol 6000 (PEG 6000) fits right in—a humble, waxy powder with plenty of uses that go far beyond what most people imagine. If you’ve swallowed a tablet, swished mouthwash, or spread on a soothing cream, there’s a fair shot you’ve brushed up against this compound.
PEG 6000 comes with well-earned credentials. The BP, EP, and USP stamps mean British Pharmacopoeia, European Pharmacopoeia, and United States Pharmacopeia—all mark a substance as meeting tough standards for safety and consistency. In simple terms, these grades mean doctors and pharmacists can trust it to do what it’s supposed to do, every single time.
Let’s take tablets. Imagine you rely on a little pill each morning for blood pressure or diabetes. The makers need those tablets not to crumble in the bottle but also to break down at just the right moment after you swallow. PEG 6000 brings both strength and flexibility, helping powders stick together during manufacturing and then dissolve properly so the medicine gets where it should go. Missing this balance invites real trouble in patient care.
Pharmacies crank out creams for eczema, ointments for burns, and more. PEG 6000 smooths out the texture of these topical medicines. No one wants to rub on a greasy, grainy lotion. PEG 6000 helps creams spread, and it helps trap medication in the right spot. Patients with sensitive skin need soothing, not irritation, so a stable and gentle base matters a lot. Reliable quality ingredients like PEG 6000 help prevent allergic reactions and unpredictable side effects.
Some medicines hate water, others break down too quickly. PEG 6000 helps science teams keep active ingredients stable and willing to mix. It acts like a middleman, coating tiny medicine particles so they stay suspended in syrups and suspensions, or dissolve smoothly when you take them by mouth. It also keeps sensitive biologic drugs from falling apart before patients can benefit. This sounds like background work, but it’s key. A medicine that won’t last through shipping or won’t dissolve is no good to sick people.
In hospital wards, PEG 6000 shows up when a patient needs gentle laxatives before surgery. Polyethylene Glycol-based solutions have less risk of dehydration than older treatments. They’re prescribed for both children and elders, who need careful dosing and dependable safety. Families reach for PEG-based products at home, whether for constipation or for a thickener in liquid nutrition.
You find news stories on the risks in the drug supply chain, contamination, and counterfeit products. Using pharma grade PEG 6000, manufacturers give patients and doctors another line of protection. Every batch has to match strict standards; audits and inspections aren’t optional. Mistakes get caught earlier, and users get more assurance that what they’re swallowing or rubbing on their skin is exactly what the doctor intended.
Pharmaceutical companies can’t cut corners here. More transparency works—everything from QR codes on medicine packs to disclosure of ingredient sources. Doctors and pharmacists should keep asking questions about excipients, not just active drugs. Patients deserve to know what’s in their treatment, and top-quality PEG 6000 plays a quiet, crucial part in keeping modern medicines both safe and effective.
Pharmaceutical production and research keep turning back to Polyethylene Glycol 6000, better known as PEG 6000. This polymer brings flexibility and reliability to the mix every time someone prepares a tablet, injects a solution, or stabilizes a protein. In my time working with raw materials in pharma labs, I noticed how the tight specs demanded by regulatory bodies really shape a day’s work. Cutting any corners with grade or quality isn’t an option. PEG 6000 holds several hats: solubilizer, ointment base, tablet binder, and much more. Its use keeps growing because it does its job cleanly — as long as it checks all the right boxes for purity and performance.
For those standing by the bench with a new drum of PEG 6000, the numbers and limits do the talking. The British Pharmacopoeia (BP), European Pharmacopoeia (EP), and United States Pharmacopeia (USP) each have sets of guidelines to define pharma grade. Here’s what I look for and why it matters.
A pharma-grade label on PEG 6000 signals that it crosses each purity checkpoint. The most reputable suppliers run their material through rigorous purification, including vacuum drying or filtration, and stamp it with certificates that come under audit regularly. Random spot checks catch anything that falls through the cracks, and regulatory audits verify every figure.
Visual checks help, but the numbers from titration, chromatography, and spectrometry matter most. Acceptance criteria for foreign substances keep a clean slate, and regulatory-grade packaging stops leaching from drums or bags. In some of the best-run sites I have seen, chemical and microbial purity are tracked batch-to-batch, not just at the start or end.
More than ever, pharma teams expect full traceability — where each drum came from, the conditions during shipping, supplier audits, all the way down to the test logs. Problems often come not from the big details but from overlooked steps: humidity spikes during storage, outdated test methods, or unclear labelling. Solutions rely on keeping every QC and QA process tight, from goods-in to release.
PEG 6000 reminds me that details in raw material handling keep the entire supply chain — and patient safety — protected. The more we stick by strict international standards and transparent sourcing, the smoother and safer things stay for everyone at the end of the line.
Polyethylene Glycol 6000 goes by PEG 6000 at pharmacies and labs. This compound shows up in everything from everyday skin creams to the pills you swallow. If you’re not paying close attention to the labels, it often blends in quietly. PEG 6000 serves as a binder, solubilizer, and thickener. In many ways, it acts like a utility player—the ingredient steps in where smoothness, moisture, or consistency matter.
With so many products using PEG 6000, concerns sometimes crop up among consumers. Folks often want to know, "Am I putting something safe on my skin, or swallowing something harmless with my medicine?"
I get these worries because labels nowadays sound like something straight out of a chemistry class. Drug and cosmetic industries both lean on PEGs for the right feel and stability. But seeing "polyethylene glycol" can make people think about plastic packaging or antifreeze, which triggers caution.
The reality is that PEG 6000 holds a place in hundreds of peer-reviewed studies, with safety results reviewed by groups like the U.S. FDA, the European Medicines Agency, and the World Health Organization. Clinical trial data shows low toxicity. In everyday terms, that means it doesn’t build up in the body, and it exits through urine without being broken down.
Folks in pharmacy know that PEG 6000 has been in syrups, tablets, ointments, and even eye drops for years, with very few reported issues for most people. I’ve filled dozens of eczema cream prescriptions where PEG 6000 binds the active drug to the base.
Still, anyone working closely with patients knows some will experience sensitivity or allergies. These are usually rare. If someone has sensitive skin, using small test patches reduces risk. Most adverse reactions tends to show up in people who already react to several ingredients, not PEG 6000 alone.
Cosmetics tell a similar story. PEG 6000 thickens lotions and creams. It helps active ingredients spread evenly, which makes it easier for both brands and users to trust what they’re getting. Dermatologists and pharmacists lean on safety studies to decide what goes on their shelves. Findings from researchers at Memorial Sloan Kettering Cancer Center show PEG allergies stay very rare, even for oncology patients using creams daily.
No discussion on PEG 6000 feels complete without mentioning contamination. The main worry isn’t the compound itself. Sometimes, during manufacturing, trace amounts of ethylene oxide or 1,4-dioxane slip in as byproducts. Both these chemicals have been flagged by groups like the International Agency for Research on Cancer. Routes for safer production exist, and regulators keep pushing for ever-stricter limits on contaminants.
From my own pharmacy experience, trusted pharmaceutical and cosmetic brands tend to work with suppliers that test every batch for impurities. These tests have teeth—if a company skips steps, it faces recalls and bans. The data points to low risk as long as good manufacturing practices get followed. Consumers who buy products from reputable sources and double-check expiry dates help this system work as intended.
Sometimes the challenge lies not in PEG 6000 itself, but in making sure manufacturers stick to strict quality controls. Transparency about ingredient sources lets consumers make better decisions. Clear labeling helps people with allergies or sensitivities avoid trouble.
Doctors, pharmacists, and researchers keep watching for reports of new issues. Regular safety reviews and spot-checks in labs catch problems early. Technology keeps improving detection limits, so impurities that slipped through twenty years ago rarely stand a chance now.
In the end, PEG 6000 remains a safe, trusted option across pharmaceuticals and cosmetics for the vast majority of users. The best recipe for safety beats any single compound: honest communication, real science, and accountability from start to finish.
Polyethylene Glycol 6000 shows up at just about every pharmaceutical facility I visit. It often looks unremarkable—either as a powder or solid flakes in sealed bags. That familiar look makes mistakes easy. I’ve seen products that lost months on the shelf just because the crew figured “it’s just another excipient.” If you don’t pay attention, you end up dealing with lumps, odd odors, or worst of all, product recalls. Suppliers urge care, but following a few grounded principles prevents a lot of headaches and protects batch quality down the road.
Every manufacturer I’ve worked with points to heat and moisture as top threats to Polyethylene Glycol’s purity. Anything above 25°C (77°F) risks slow but steady degradation, especially with India’s humid climate. Get a dry, temperature-controlled room and keep it away from direct sun—the heat builds up in plastic drums faster than you think. Even a modest AC system pays for itself, especially if you handle large volumes each quarter.
Humidity does more harm than a slight temperature swing. I met a facility operator who started noticing cakes forming inside drums after a week of monsoon season. That wasn’t a coincidence: Polyethylene Glycol pulls water out of the air and forms hard clumps, sometimes making it impossible to weigh accurately during formulation. Use a dehumidifier if you work in regions where relative humidity stays above 60 percent. Always close bags tightly after each use, and avoid transferring product in open air where water vapor can slip in.
I’ve heard from countless line workers that a dusty scooping area just makes cleanup harder. But in practice, the real issue is cross-contamination. A single scoop used for multiple products risks introducing foreign materials, which is a red flag for the lab and a regulatory risk during audits. Use dedicated tools for scooping and transfer, and make sure gloves and aprons get changed between products—no exceptions for “just a small batch.” Always document batch numbers and handling personnel because proper traceability matters in case teams need to pull a sample for analysis later.
One lab in Europe nearly lost a full pallet to a spill from a neighboring acid drum. Even though Polyethylene Glycol 6000 stands up to many chemicals, acids, and strong oxidizers break it down or turn it yellow, which means expensive disposal. I urge anyone storing this excipient to keep it well-separated from cleaning agents, acids, and even strong perfumes or volatile solvents. Segregate sensitive materials and keep an updated inventory nearby so teams know what sits in storage at a glance.
Labels often fade or peel away after a few humid months. In one instance, a missing expiry date sent an entire lot back for lab re-testing. Don’t rely only on the supplier’s markings—apply your own clear, laminated labels on every bag or drum. Rotate stock using a simple FIFO system and periodically recheck stored products for changes in texture or smell. Even with perfect records, nothing beats a physical check every quarter by someone who knows what good Polyethylene Glycol looks and smells like.
Pharmaceutical grade Polyethylene Glycol 6000 may seem straightforward on a supply sheet, but careless storage or handling can undermine months of careful formulation. Secure packaging, clean workspaces, moderate climate, and clear labeling keep every batch safe, cost-effective, and above all, trusted by both regulators and patients alike.
Working with pharmaceutical raw materials, I’ve noticed packaging decisions land near the top of every checklist—especially with sensitive ingredients like Polyethylene Glycol 6000. Humidity brings headaches, contaminated scoops ruin batches, and even minor leaks snowball into costly recalls. Pharmacopeia-grade PEG 6000 demands containers that stand up to strict standards, so mistakes here lead to real risks for safety and reliability.
Over the years, I’ve torn open plenty of different bags and barrels containing this versatile polymer. Most suppliers offer PEG 6000 as a solid, either in coarse flakes or powder. Every packaging choice comes with trade-offs, so it helps to see these options in the wild—factories, distribution hubs or even while standing in a cramped warehouse.
One major advantage shows up in the form of sturdy HDPE drums, most commonly in 25 or 50 kilogram sizes. These containers shrug off splashes, don’t rust, and keep their cool in humid or hot climates. After a long journey across continents, they keep out the moisture—critical for a polymer highly sensitive to water uptake. I’ve seen HDPE barrels stacked three high, enduring forklift bumps and still protecting the PEG inside.
Pharmaceutical manufacturers prefer laminated paper bags lined with polyethylene or foil for several reasons. The paper outer shell absorbs minor shocks and helps with stacking. The liner blocks moisture and keeps out strange odors. Polyethylene and aluminum liners serve separate needs—poly liners work for short moves, foil adds shelf-life where humidity swings need taming. Weight runs between 20 and 25 kilograms per bag. To avoid caking or accidental mixing, color coding or barcoding gets used for fast identification on the plant floor.
In tightly regulated plants, fiberboard cartons sometimes come double-lined with interior barrier bags or pouches. While boxes don’t win awards for ruggedness, their square edges and stackability make them convenient on pallets. Smaller 5 or 10 kilogram units go this route, especially for smaller batch or specialty manufacturing. It’s easier to break down a single box at a time in a compounding pharmacy than open a drum for a tiny prescription batch.
I’ve also seen manufacturers supply pre-weighed sachets or flexible pouches for research labs and quality control applications, usually in 500-gram or one-kilogram units. These get sealed in controlled rooms to block humidity shifts. Handling smaller formats leaves little room for error and helps with traceability—a growing trend as digital inventory tracking gets more attention in Good Manufacturing Practice.
Pharma-grade supply chains sometimes ignore how rough shipping gets between continents. For instance, a paper bag that survives a European winter might not hold up in the muggy finale of a Southeast Asian port. More suppliers now double up on liners, include moisture indicator strips, or vacuum-seal product to avoid caking disasters. I’ve even seen some companies spring for tamper-evident or RFID-enabled seals to better track and trace sensitive shipments.
Choosing packaging involves a careful balance. Compliance with pharmacopeia demands, preserving ingredient quality, and working within cost constraints create the puzzle. Those who work with these raw materials day-to-day appreciate containers that protect the investment—and help deliver safer medicine.
Chengguan District, Lanzhou, Gansu, China
